Cargando…
Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
Anti-programmed cell death protein 1 (PD-1) agents have become the standard of care for platinum-refractory recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) and are currently being evaluated in various disease settings. However, despite the gain in overall survival seen in some of...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336003/ https://www.ncbi.nlm.nih.gov/pubmed/30462163 http://dx.doi.org/10.1093/annonc/mdy507 |